Regenerative Therapies for Articular Cartilage: Current Concepts, Clinical Outcomes, and Future Directions
DOI:
https://doi.org/10.12775/JEHS.2026.90.70255Keywords
Articular cartilage regeneration, Mesenchymal stem cells, Tissue engineering, Regenerative medicine, Cartilage repair, OsteoarthritisAbstract
Introduction and purpose. Articular cartilage injuries represent a significant clinical challenge due to the tissue’s limited intrinsic healing capacity, often progressing to osteoarthritis and chronic disability. Traditional treatments remain largely symptomatic, prompting extensive research into regenerative therapies aimed at restoring functional cartilage tissue.
Description of the state of knowledge. We conducted a systematic analysis of recent literature (2020-2026) encompassing randomized controlled trials, systematic reviews, meta-analyses, and prospective cohort studies. Evidence was synthesized across multiple therapeutic modalities including mesenchymal stem cells (MSCs), autologous chondrocyte implantation (ACI/MACI), platelet-rich plasma (PRP), osteochondral transplantation, tissue engineering scaffolds, and emerging technologies such as 3D bioprinting, gene therapy, and exosome-based treatments. Matrix-associated autologous chondrocyte implantation (MACI) demonstrates significant long-term efficacy with large effect sizes (>0.8) in patient-reported outcomes at 2-15 years follow-up. Mesenchymal stem cells from various sources (bone marrow, adipose tissue, synovium, umbilical cord) show promise in clinical trials, with synovium-derived MSCs exhibiting particularly high chondrogenic potential. Comparative studies indicate that ACI/MACI and expanded MSC transplantation outperform microfracture for focal cartilage defects.
Summary. Regenerative therapies have evolved significantly, with cell-based approaches demonstrating superior outcomes compared to traditional marrow stimulation techniques. However, challenges persist regarding optimal cell source, dosage, delivery methods, and long-term durability. Standardized protocols, large-scale randomized trials, and integration of emerging technologies are essential to advance the field toward personalized, effective cartilage regeneration strategies.
References
1. Roseti L, et al. Forty Years of the Use of Cells for Cartilage Regeneration: The Research Side. Pharmaceutics. 2024;16(12):1622. https://doi.org/10.3390/pharmaceutics16121622
2. Thoene M, et al. The Current State of Osteoarthritis Treatment Options Using Stem Cells for Regenerative Therapy: A Review. Int J Mol Sci. 2023;24(8):8925. https://doi.org/10.3390/ijms24088925
3. Meng W, et al. Adipose Tissue-Derived Mesenchymal Stem Cells As a Potential Restorative Treatment for Cartilage Defects: A PRISMA Review and Meta-Analysis. Pharmaceuticals. 2021;14(12):1280. https://doi.org/10.3390/ph14121280
4. Liu Y, et al. Osteoarthritis: Mechanisms and Therapeutic Advances. MedComm. 2025;6(1):e70290. https://doi.org/10.1002/mco2.70290
5. Uchio Y, et al. Effectiveness and safety of matrix-associated autologous chondrocyte implantation for the treatment of articular cartilage defects: a real-world data analysis in Japan. Am J Sports Med. 2024;52(12):3082-3091. https://doi.org/10.1177/03635465241282671
6. Cong L, et al. Stem cell-based cartilage regeneration: Biological strategies, engineering innovations, and clinical translation. World J Stem Cells. 2025;17(9):108523. https://doi.org/10.4252/wjsc.v17.i9.108523
7. Chen Y, et al. Advancements in tissue engineering for articular cartilage regeneration. Heliyon. 2024;10(3):e25400. https://doi.org/10.1016/j.heliyon.2024.e25400
8. Jung YH, et al. Allogeneic umbilical cord blood-derived mesenchymal stem cell implantation versus microdrilling combined with high tibial osteotomy for cartilage regeneration. Sci Rep. 2024;14(1):3598. https://doi.org/10.1038/s41598-024-53598-9
9. Ebert JR, et al. Long-term prospective clinical and magnetic resonance imaging–based evaluation of matrix-induced autologous chondrocyte implantation. Am J Sports Med. 2021;49(3):631-641. https://doi.org/10.1177/0363546520980109
10. Islam A, et al. Regenerative Medicine in Orthopaedic Surgery: Pioneering Advances and Their Applications. EMJ Innov. 2024;2(1):38-46. https://doi.org/10.33590/emjinnov/fgds3814
11. Xue K, et al. Genetically modified mesenchymal stromal cells in cartilage regeneration. Stem Cells Dev. 2023;32(7-8):187-201. https://doi.org/10.1089/scd.2022.0242
12. Focşa IO, et al. Emerging Strategies in Cartilage Repair and Joint Preservation. Medicina. 2024;61(1):24. https://doi.org/10.3390/medicina61010024
13. Wang D, et al. Minimum 10-year outcomes of matrix-induced autologous chondrocyte implantation in the knee: a systematic review. Am J Sports Med. 2024;52(11):2947-2958. https://doi.org/10.1177/03635465231205309
14. Campbell TM, et al. The Hunt Is On! In Pursuit of the Ideal Stem Cell Population for Cartilage Regeneration. Front Bioeng Biotechnol. 2022;10:866148. https://doi.org/10.3389/fbioe.2022.866148
15. Lohrasbi S, et al. Efficacy based on dose-response and safety of bone marrow-derived mesenchymal stem cells for the treatment of osteoarthritis: a systematic review and meta-analysis. Stem Cell Res Ther. 2025;16(1):799. https://doi.org/10.1186/s13287-025-04799-0
16. Calvi EN, et al. Knee articular cartilage injury treatment with matrix-induced autologous chondrocyte implantation (MACI): correlation at 24 and 120 months between clinical and MRI findings. Skeletal Radiol. 2022;51(6):1273-1281. https://doi.org/10.1007/s00256-021-03968-5
17. Venosa M, et al. Platelet‐Rich Plasma and Adipose‐Derived Mesenchymal Stem Cells in Association with Arthroscopic Microfracture of Knee Articular Cartilage Defects: A Pilot Study. Arthroscopy. 2020;36(3):e1-e2. https://doi.org/10.1016/j.arthro.2019.11.119
18. Saris DBF, et al. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med. 2009;37(10):1958-1965. https://doi.org/10.1177/0363546509350694
19. Barié A, et al. Prospective long-term follow-up of autologous chondrocyte implantation with periosteum versus matrix-associated autologous chondrocyte implantation: a comparative study. Am J Sports Med. 2020;48(9):2230-2241. https://doi.org/10.1177/0363546520928336
20. Nassar I, et al. Autologous chondrocyte implantation, matrix‐induced autologous chondrocyte implantation, osteochondral autograft transplantation and osteochondral allograft transplantation: a comparative review. ANZ J Surg. 2021;91(12):2567-2576. https://doi.org/10.1111/ans.17176
21. Andriolo L, et al. Long-term results of arthroscopic matrix-assisted autologous chondrocyte transplantation: a prospective follow-up at 15 years. Am J Sports Med. 2020;48(14):3423-3433. https://doi.org/10.1177/0363546520949849
22. Muthu S, et al. Clinical Effectiveness of Various Treatments for Cartilage Defects Compared to Microfracture: a Network Meta-analysis of Randomized Controlled Trials. J Cartilage Joint Preserv. 2023;3(4):100163. https://doi.org/10.1016/j.jcjp.2023.100163
23. Dhillon MS, et al. Third-Generation Autologous Chondrocyte Implantation (Cells Cultured Within Collagen Membrane) versus Microfracture for Focal Chondral Defects of the Knee Joint: A Systematic Review of Randomized Controlled Trials at Minimum Two-Year Follow-Up. Arthroscopy. 2022;38(7):2278-2291. https://doi.org/10.1016/j.arthro.2022.02.011
24. Chiang ER, et al. Expanded Mesenchymal Stem Cell Transplantation Following Marrow Stimulation Is More Effective Than Marrow Stimulation Alone in Treatment of Knee Cartilage Defect: A Systematic Review and Meta-Analysis. Orthop Traumatol Surg Res. 2020;106(6):1151-1158. https://doi.org/10.1016/J.OTSR.2020.04.008
25. Gou GH, et al. Autologous Chondrocyte Implantation Versus Microfracture in the Knee: A Meta-analysis and Systematic Review. Arthroscopy. 2020;36(1):289-303. https://doi.org/10.1016/J.ARTHRO.2019.06.033
26. Wang T, et al. Characteristics and Clinical Outcomes After Osteochondral Allograft Transplantation for Treating Articular Cartilage Defects: Systematic Review and Single-Arm Meta-analysis of Studies From 2001 to 2020. Orthop J Sports Med. 2023;11(9):23259671231199418. https://doi.org/10.1177/23259671231199418
27. Grossman J, et al. Matrix-Induced Autologous Chondrocyte Implantation (MACI) is Largely Effective and Provides Significant Improvement in Patients With Symptomatic, Large Chondral Defects: A Systematic Review and Meta-Analysis. Surg Technol Int. 2022;41:OS1613. https://doi.org/10.52198/22.sti.41.os1613
28. Tan J, et al. Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis. Front Bioeng Biotechnol. 2024;12:1309946 https://doi:10.3389/fbioe.2024.1309946
29. Koch M, et al. The patient acceptable symptomatic state for commonly used outcome scores 10 years after matrix-associated autologous chondrocyte implantation. Knee Surg Sports Traumatol Arthrosc. 2026;34(1):661-670. https://doi.org/10.1002/ksa.12661
30. Jafari A, et al. The Emerging Role of Synovium-Derived Mesenchymal Stem Cells in Articular Cartilage Regeneration: A Systematic Review of Clinical and Translational Studies. Res Sq. 2025. https://doi.org/10.21203/rs.3.rs-7292857/v1
31. Primorac D, et al. Tissue engineering and future directions in regenerative medicine for knee cartilage repair: a comprehensive review. Croat Med J. 2024;65(4):268-289. https://doi.org/10.3325/cmj.2024.65.268
32. Singh A, et al. Osteoarthritis: insights into pathogenesis and futuristic treatment strategies. Int J Res Orthop. 2022;8(5):1009-1016. https://doi.org/10.18203/issn.2455-4510.intjresorthop20222722
33. Xavier JR, et al. Exosome-laden scaffolds for treatment of post-traumatic cartilage injury and osteoarthritis of the knee: a systematic review. Int J Mol Sci. 2023;24(20):15178. https://doi.org/10.3390/ijms242015178
34. Szychlinska MA, et al. Three-Dimensional Bioprinting for Cartilage Tissue Engineering: Insights into Naturally-Derived Bioinks from Land and Marine Sources. J Funct Biomater. 2022;13(3):118. https://doi.org/10.3390/jfb13030118
35. Yüksel E. Advanced 3D Bioprinting Techniques for Regenerative Medicine: Exploring Applications in Tissue Engineering and Personalized Therapeutics. Preprints. 2024. https://doi.org/10.62802/xa2ak830
36. Smolinska V, et al. Implication of Mesenchymal Stem Cells and Their Derivates for Osteochondral Regeneration. Int J Mol Sci. 2022;23(5):2490. https://doi.org/10.3390/ijms23052490
37. Loukelis K, et al. Advances in 3D bioprinting for regenerative medicine applications. Regen Biomater. 2024;11:rbae033. https://doi.org/10.1093/rb/rbae033
38. Rathod A, et al. Platelet rich plasma applications in orthopedics: A review of recent advances. World J Orthop. 2025;16(12):1103-1115. https://doi.org/10.5312/wjo.v16.i12.110377
39. Jiang W, et al. Fabrication of collagen-based biomaterials for sports medicine application. Regen Biomater. 2025;12:rbaf116. https://doi.org/10.1093/rb/rbaf116
40. Lafuente-Merchan M, et al. Progress in 3D bioprinting technology for osteochondral regeneration. Pharmaceutics. 2022;14(8):1578. https://doi.org/10.3390/pharmaceutics14081578
41. Hevesi M, et al. Emerging Cartilage Repair Options. In: Cartilage Injury in the Athlete. Springer; 2021:371-385. https://doi.org/10.1007/978-3-030-78051-7_24
42. Jiang Y, et al. Research Progress on Stem Cell Therapies for Articular Cartilage Regeneration. Stem Cells Int. 2021;2021:88
43. 82505. https://doi.org/10.1155/2021/8882505
44. Chen X, et al. Biomaterial-Based Gene Delivery: Advanced Tools for Enhanced Cartilage Regeneration. Drug Des Devel Ther. 2023;17:3473-3492. https://doi.org/10.2147/dddt.s432056
45. Li Z, et al. Effects of rAAV-Mediated Overexpression of sox9 and TGF-ß via Alginate Hydrogel-Guided Vector Delivery on the Chondroreparative Activities of Human Bone Marrow-Derived Mesenchymal Stromal Cells. J Tissue Eng Regen Med. 2023;2023:4495697. https://doi.org/10.1155/2023/4495697
46. Venkatesan JK, et al. pNaSS-Grafted PCL Film-Guided rAAV TGF-β Gene Therapy Activates the Chondrogenic Activities in Human Bone Marrow Aspirates. Hum Gene Ther. 2021;32(19-20):1176-1188. https://doi.org/10.1089/HUM.2020.329
47. Bonato A, et al. Engineering Inflammation‐Resistant Cartilage: Bridging Gene Therapy and Tissue Engineering. Adv Healthc Mater. 2023;12(20):2202271. https://doi.org/10.1002/adhm.202202271
48. Meng W, et al. rAAV-Mediated Overexpression of SOX9 and TGF-β via Carbon Dot-Guided Vector Delivery Enhances the Biological Activities in Human Bone Marrow-Derived Mesenchymal Stromal Cells. Nanomaterials. 2020;10(5):855. https://doi.org/10.3390/NANO10050855
49. Chae DS, et al. IGF-1 Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis. Int J Mol Sci. 2024;25(8):4442. https://doi.org/10.3390/ijms25084442
50. Choe R, et al. Biomechanical aspects of osteochondral regeneration: implications and strategies for three-dimensional bioprinting. Tissue Eng Part B Rev. 2021;27(6):565-585. https://doi.org/10.1089/TEN.TEB.2021.0101
51. Yoo J, et al. Transforming growth factor-β family and stem cell-derived exosome therapeutic treatment in osteoarthritis (Review). Int J Mol Med. 2022;49(5):118. https://doi.org/10.3892/ijmm.2022.5118
52. Venkatesan JK, et al. Biomaterial-Assisted Gene Therapy for Translational Approaches to Treat Musculoskeletal Disorders. Mater Today Adv. 2021;9:100126. https://doi.org/10.1016/J.MTADV.2020.100126
53. Goh BC, et al. Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review. Bioengineering. 2023;10(3):355. https://doi.org/10.3390/bioengineering10030355
54. Cole BJ, et al. Optimizing Patient Outcomes Following Osteochondral Allograft Transplantation: The Impact of 25 Years of Translational and Clinical Research. J Orthop Res. 2025;43(3):489-502. https://doi.org/10.1002/jor.26089
55. Veiseh O, et al. Engineering the next generation of cell-based therapeutics. Nat Rev Drug Discov. 2022;21(9):655-675. https://doi.org/10.1038/s41573-022-00476-6
56. Zhang Y, et al. Sodium alginate hydrogels co-encapsulated with cell free fat extract-loaded core-shell nanofibers and menstrual blood stem cells derived exosomes for acceleration of articular cartilage regeneration. Int J Biol Macromol. 2024;280:135851. https://doi.org/10.1016/j.ijbiomac.2024.135851
57. Hu H, et al. miR-23a-3p-abundant small extracellular vesicles released from Gelma/nanoclay hydrogel for cartilage regeneration. J Extracell Vesicles. 2020;9(1):1778883. https://doi.org/10.1080/20013078.2020.1778883
58. Li M, et al. 3D printing of microenvironment‐specific bioinspired and exosome‐reinforced hydrogel scaffolds for efficient cartilage and subchondral bone regeneration. Adv Sci. 2023;10(31):2303650. https://doi.org/10.1002/advs.202303650
59. Truong NF, et al. Bioprinting the Osteochondral Interface: Advances, Challenges, and Future Directions. Tissue Eng Part A. 2025;31(1-2):3-18. https://doi.org/10.1177/19373341251410101
60. Jiao Z, et al. 3D-Printed Constructs Deliver Bioactive Cargos to Expedite Cartilage Regeneration. J Pharm Anal. 2023;13(12):1465-1481. https://doi.org/10.1016/j.jpha.2023.12.015
61. Blevins K, et al. In situ 3D bioprinting of musculoskeletal tissues in orthopedic surgery. J 3D Print Med. 2022;6(1):7-22. https://doi.org/10.2217/3dp-2021-0022
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jan Domińczak, Adam Dobosz, Antoni Wojnowski, Sofia Czarnecka, Gabriela Łuczyńska, Joanna Banatkiewicz, Emilia Deka, Hanna Bojanowska, Karolina Babik, Oliwia Bartkowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 4
Number of citations: 0
